ALX ONCOLOGY HOLDINGS INC (ALXO) Operating cash flow 2018–2025
ALX ONCOLOGY HOLDINGS INC (ALXO) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$84.1MFY2025 · since FY2018: -$13.2M → -$84.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$84.1M | +31.0% |
| FY2024 | -$121.9M | +6.5% |
| FY2023 | -$130.4M | -46.1% |
| FY2022 | -$89.2M | -31.0% |
| FY2021 | -$68.1M | -77.9% |
| FY2020 | -$38.3M | -168.7% |
| FY2019 | -$14.2M | -8.0% |
| FY2018 | -$13.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice